IL1B and prostate carcinoma: In a case-control study, individuals carrying the IL-1β (rs16944 and rs1143627) AG genotype were related with a lowered risk of prostate cancer as determined by real-time polymerase chain reaction of blood samples from 71 prostate cancer cases and 76 controls (32).